APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acquired Immunodeficiency Syndrome

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Acquired Immunodeficiency Syndrome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchAcquired Immunodeficiency Syndrome Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acquired Immunodeficiency Syndrome Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Acquired Immunodeficiency Syndrome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acquired Immunodeficiency Syndrome Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Acquired Immunodeficiency Syndrome Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Acquired Immunodeficiency Syndrome market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Acquired Immunodeficiency Syndrome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acquired Immunodeficiency Syndrome include Takeda, Sanofi, Novartis, Pfizer, Amgen, Merck KGaA, Daiichi Sankyo Company, Biogen and AstraZeneca Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Acquired Immunodeficiency Syndrome market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acquired Immunodeficiency Syndrome and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acquired Immunodeficiency Syndrome revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Acquired Immunodeficiency Syndrome market size, projected growth trends, production technologies, key applications, and end-use industries.

Acquired Immunodeficiency Syndrome Segment by Company

Takeda

Sanofi

Novartis

Pfizer

Amgen

Merck KGaA

Daiichi Sankyo Company

Biogen

AstraZeneca Eli Lilly and Company

Actelion

Acquired Immunodeficiency Syndrome Segment by Type

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Acquired Immunodeficiency Syndrome Segment by Application

Hospital Pharmacy

Retail Pharmacy

Others

Acquired Immunodeficiency Syndrome Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acquired Immunodeficiency Syndrome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acquired Immunodeficiency Syndrome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acquired Immunodeficiency Syndrome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Acquired Immunodeficiency Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acquired Immunodeficiency Syndrome industry.

Chapter 3: Detailed analysis of Acquired Immunodeficiency Syndrome companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acquired Immunodeficiency Syndromerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Table 3. Key Players of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Table 4. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacy Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Others Table 8. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Acquired Immunodeficiency Syndrome Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Acquired Immunodeficiency Syndrome Market Share by Region (2021-2026) Table 11. Global Acquired Immunodeficiency Syndrome Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Acquired Immunodeficiency Syndrome Market Share by Region (2027-2032) Table 13. Acquired Immunodeficiency Syndrome Industry Trends Table 14. Acquired Immunodeficiency Syndrome Industry Drivers Table 15. Acquired Immunodeficiency Syndrome Industry Opportunities and Challenges Table 16. Acquired Immunodeficiency Syndrome Industry Restraints Table 17. Global Acquired Immunodeficiency Syndrome Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Company (2021-2026) Table 19. Global Acquired Immunodeficiency Syndrome Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Acquired Immunodeficiency Syndrome Key Company Head Office and Area Served Table 21. Global Acquired Immunodeficiency Syndrome Company, Product Type & Application Table 22. Global Acquired Immunodeficiency Syndrome Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Acquired Immunodeficiency Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Acquired Immunodeficiency Syndrome Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2021-2026) Table 29. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2027-2032) Table 30. Global Acquired Immunodeficiency Syndrome Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2021-2026) Table 34. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Acquired Immunodeficiency Syndrome Product Portfolio Table 39. Takeda Recent Development Table 40. Sanofi Company Information Table 41. Sanofi Business Overview Table 42. Sanofi Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Sanofi Acquired Immunodeficiency Syndrome Product Portfolio Table 44. Sanofi Recent Development Table 45. Novartis Company Information Table 46. Novartis Business Overview Table 47. Novartis Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis Acquired Immunodeficiency Syndrome Product Portfolio Table 49. Novartis Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Acquired Immunodeficiency Syndrome Product Portfolio Table 54. Pfizer Recent Development Table 55. Amgen Company Information Table 56. Amgen Business Overview Table 57. Amgen Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Amgen Acquired Immunodeficiency Syndrome Product Portfolio Table 59. Amgen Recent Development Table 60. Merck KGaA Company Information Table 61. Merck KGaA Business Overview Table 62. Merck KGaA Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck KGaA Acquired Immunodeficiency Syndrome Product Portfolio Table 64. Merck KGaA Recent Development Table 65. Daiichi Sankyo Company Company Information Table 66. Daiichi Sankyo Company Business Overview Table 67. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Portfolio Table 69. Daiichi Sankyo Company Recent Development Table 70. Biogen Company Information Table 71. Biogen Business Overview Table 72. Biogen Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Biogen Acquired Immunodeficiency Syndrome Product Portfolio Table 74. Biogen Recent Development Table 75. AstraZeneca Eli Lilly and Company Company Information Table 76. AstraZeneca Eli Lilly and Company Business Overview Table 77. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Portfolio Table 79. AstraZeneca Eli Lilly and Company Recent Development Table 80. Actelion Company Information Table 81. Actelion Business Overview Table 82. Actelion Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Actelion Acquired Immunodeficiency Syndrome Product Portfolio Table 84. Actelion Recent Development Table 85. North America Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) Table 91. North America Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032) Table 92. Europe Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) Table 98. Europe Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032) Table 99. China Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 100. China Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 101. China Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 102. China Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) Table 109. Asia Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Acquired Immunodeficiency Syndrome Product Image Figure 2. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Acquired Immunodeficiency Syndrome Market Share by Type: 2025 VS 2032 Figure 4. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Image Figure 5. Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Image Figure 6. Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Acquired Immunodeficiency Syndrome Market Share by Application: 2025 VS 2032 Figure 8. Hospital Pharmacy Image Figure 9. Retail Pharmacy Image Figure 10. Others Image Figure 11. Global Acquired Immunodeficiency Syndrome Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 13. Global Acquired Immunodeficiency Syndrome Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Acquired Immunodeficiency Syndrome Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Acquired Immunodeficiency Syndrome Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Acquired Immunodeficiency Syndrome Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Type (2021-2032) Figure 20. Global Acquired Immunodeficiency Syndrome Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Acquired Immunodeficiency Syndrome Revenue Market Share by Application (2021-2032) Figure 22. North America Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 23. North America Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032) Figure 24. North America Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032) Figure 25. North America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 26. United States Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 27. Canada Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 29. Europe Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 30. Europe Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032) Figure 31. Europe Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032) Figure 32. Europe Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 33. Germany Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 34. France Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 36. Italy Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 37. Russia Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 39. China Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 40. China Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032) Figure 41. China Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032) Figure 42. Asia Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 43. Asia Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032) Figure 44. Asia Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032) Figure 45. Asia Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 46. Japan Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 50. India Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 51. Australia Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032) Figure 56. Brazil Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 61. UAE Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 63. Chile Acquired Immunodeficiency Syndrome Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Novartis
  • Pfizer
  • Amgen
  • Merck KGaA
  • Daiichi Sankyo Company
  • Biogen
  • AstraZeneca Eli Lilly and Company
  • Actelion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  5. 1.2.3 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Acquired Immunodeficiency Syndrome Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacy
  9. 1.3.3 Retail Pharmacy
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Acquired Immunodeficiency Syndrome Growth Trends by Region
  13. 1.5.1 Global Acquired Immunodeficiency Syndrome Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Acquired Immunodeficiency Syndrome Market Size by Region (2021-2026)
  15. 1.5.3 Acquired Immunodeficiency Syndrome Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Acquired Immunodeficiency Syndrome Market Dynamics
  1. 2.1 Acquired Immunodeficiency Syndrome Industry Trends
  2. 2.2 Acquired Immunodeficiency Syndrome Industry Drivers
  3. 2.3 Acquired Immunodeficiency Syndrome Industry Opportunities and Challenges
  4. 2.4 Acquired Immunodeficiency Syndrome Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Acquired Immunodeficiency Syndrome Revenue by Company (2021-2026)
  2. 3.2 Global Acquired Immunodeficiency Syndrome Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Acquired Immunodeficiency Syndrome Key Company Head office and Area Served
  4. 3.4 Global Acquired Immunodeficiency Syndrome Company, Product Type & Application
  5. 3.5 Global Acquired Immunodeficiency Syndrome Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Acquired Immunodeficiency Syndrome Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Acquired Immunodeficiency Syndrome Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Acquired Immunodeficiency Syndrome Tier 1, Tier 2, and Tier 3
4 Acquired Immunodeficiency Syndrome Market by Type
  1. 4.1 Global Acquired Immunodeficiency Syndrome Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Acquired Immunodeficiency Syndrome Market Size by Type (2021-2032)
  3. 4.3 Global Acquired Immunodeficiency Syndrome Market Size Share by Type (2021-2032)
5 Acquired Immunodeficiency Syndrome Market by Application
  1. 5.1 Global Acquired Immunodeficiency Syndrome Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Acquired Immunodeficiency Syndrome Market Size by Application (2021-2032)
  3. 5.3 Global Acquired Immunodeficiency Syndrome Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Acquired Immunodeficiency Syndrome Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Acquired Immunodeficiency Syndrome Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis Acquired Immunodeficiency Syndrome Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Acquired Immunodeficiency Syndrome Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Amgen Acquired Immunodeficiency Syndrome Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Merck KGaA
  32. 6.6.1 Merck KGaA Company Information
  33. 6.6.2 Merck KGaA Business Overview
  34. 6.6.3 Merck KGaA Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck KGaA Acquired Immunodeficiency Syndrome Product Portfolio
  36. 6.6.5 Merck KGaA Recent Developments
  37. 6.7 Daiichi Sankyo Company
  38. 6.7.1 Daiichi Sankyo Company Company Information
  39. 6.7.2 Daiichi Sankyo Company Business Overview
  40. 6.7.3 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Daiichi Sankyo Company Acquired Immunodeficiency Syndrome Product Portfolio
  42. 6.7.5 Daiichi Sankyo Company Recent Developments
  43. 6.8 Biogen
  44. 6.8.1 Biogen Company Information
  45. 6.8.2 Biogen Business Overview
  46. 6.8.3 Biogen Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biogen Acquired Immunodeficiency Syndrome Product Portfolio
  48. 6.8.5 Biogen Recent Developments
  49. 6.9 AstraZeneca Eli Lilly and Company
  50. 6.9.1 AstraZeneca Eli Lilly and Company Company Information
  51. 6.9.2 AstraZeneca Eli Lilly and Company Business Overview
  52. 6.9.3 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca Eli Lilly and Company Acquired Immunodeficiency Syndrome Product Portfolio
  54. 6.9.5 AstraZeneca Eli Lilly and Company Recent Developments
  55. 6.10 Actelion
  56. 6.10.1 Actelion Company Information
  57. 6.10.2 Actelion Business Overview
  58. 6.10.3 Actelion Acquired Immunodeficiency Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Actelion Acquired Immunodeficiency Syndrome Product Portfolio
  60. 6.10.5 Actelion Recent Developments
7 North America
  1. 7.1 North America Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  2. 7.2 North America Acquired Immunodeficiency Syndrome Market Size by Type
  3. 7.2.1 North America Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026)
  4. 7.2.2 North America Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032)
  5. 7.2.3 North America Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032)
  6. 7.3 North America Acquired Immunodeficiency Syndrome Market Size by Application
  7. 7.3.1 North America Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026)
  8. 7.3.2 North America Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032)
  9. 7.3.3 North America Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032)
  10. 7.4 North America Acquired Immunodeficiency Syndrome Market Size by Country
  11. 7.4.1 North America Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  13. 7.4.3 North America Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032)
  14. 7.4.4 North America Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  2. 8.2 Europe Acquired Immunodeficiency Syndrome Market Size by Type
  3. 8.2.1 Europe Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026)
  4. 8.2.2 Europe Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032)
  5. 8.2.3 Europe Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032)
  6. 8.3 Europe Acquired Immunodeficiency Syndrome Market Size by Application
  7. 8.3.1 Europe Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026)
  8. 8.3.2 Europe Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032)
  9. 8.3.3 Europe Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032)
  10. 8.4 Europe Acquired Immunodeficiency Syndrome Market Size by Country
  11. 8.4.1 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  13. 8.4.3 Europe Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032)
  14. 8.4.4 Europe Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  2. 9.2 China Acquired Immunodeficiency Syndrome Market Size by Type
  3. 9.2.1 China Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026)
  4. 9.2.2 China Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032)
  5. 9.2.3 China Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032)
  6. 9.3 China Acquired Immunodeficiency Syndrome Market Size by Application
  7. 9.3.1 China Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026)
  8. 9.3.2 China Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032)
  9. 9.3.3 China Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  2. 10.2 Asia Acquired Immunodeficiency Syndrome Market Size by Type
  3. 10.2.1 Asia Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026)
  4. 10.2.2 Asia Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032)
  5. 10.2.3 Asia Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032)
  6. 10.3 Asia Acquired Immunodeficiency Syndrome Market Size by Application
  7. 10.3.1 Asia Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026)
  8. 10.3.2 Asia Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032)
  9. 10.3.3 Asia Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032)
  10. 10.4 Asia Acquired Immunodeficiency Syndrome Market Size by Country
  11. 10.4.1 Asia Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  13. 10.4.3 Asia Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032)
  14. 10.4.4 Asia Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Acquired Immunodeficiency Syndrome Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst